Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$553.7M
41M shares
52-week range
$8.36 – $13.99
86% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
www.angiodynamics.comNo one on the platform currently holds ANGO.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 803,283 | $9.1M |
No one on the platform has traded ANGO yet.
$ANGO been in this for a while CEO hunt still in progress. Maybe they will announce next earnings report? Due this summer.
View on StockTwits ↗$ANGO Med Tech Gem Such a well run company - no debt and cash flow can furnish all its future growth No major dilution Tiny Share Float 40M shared outstanding All med tech segments double digit growth yoy Nano Knife game changer for prostate cancer Tam 2B Steve Cohen has 8% stake in this company(feel free to google him) This will be a 100+ stock Insurance coverage expanding recent CPT1 code approval and expanding $XBI $IWM $IHI
View on StockTwits ↗$ANGO 70,000 shared in the first 10 minutes of trading. For this one, that’s substantial!!
View on StockTwits ↗$ANGO starting to cook and its still not widely known.. holding til 100
View on StockTwits ↗$ANGO yall dont listen ive been giving mostly winning tips for days $XBI $IHI $IWM great volume today
View on StockTwits ↗Wall St is expecting -0.09 EPS for $ANGO Q4 [Reporting 07/21 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗$ANGO received FDA Investigational Device Exemption approval for its RELIEF feasibility study to evaluate the safety and effectiveness of its NanoKnife irreversible electroporation system. https://prismmarketview.com/companies/angiodynamics-inc/#about
View on StockTwits ↗$ANGO 08:37 on Jun. 17 2026 AngioDynamics Says FDA Approves IDE Application To Initiate RELIEF Study Evaluating NanoKnife IRE Platform As Minimally Invasive Treatment Option For Men With Benign Prostatic Hyperplasia #tradeideas
View on StockTwits ↗$ANGO simplified focus on med tech product lines in last 5 years All segments showing top line yoy growth in double digits Nanoknife TAM 2B with CPT1 Code just recently approved with very high treatment interest for Prostate Cancer Time Magazine named Nanoknife top invention of 2025 Clean Balance Sheet No Debt with cash to fund all future growth Strong future pipeline Steve Cohen increased ownership to 7.7%*trust the billionaires owner of mets* Priced very cheaply compared to future growth HOLD til its SOLD
View on StockTwits ↗$ANGO great call today number 1 sleeper pick $XBI $IWM $IHI
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.